| scholarly article | Q13442814 |
| P2093 | author name string | Somasundaram S | |
| Gazzard BG | |||
| Bjarnason I | |||
| Macpherson A | |||
| Francis N | |||
| Sharpstone D | |||
| Menzies IS | |||
| Price AB | |||
| Keating J | |||
| Smithson J | |||
| P2860 | cites work | Intestinal permeability in patients with Crohn's disease and their first degree relatives | Q34375097 |
| Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis | Q34527518 | ||
| Practical advice for the gastroenterologist dealing with symptomatic HIV disease | Q37941111 | ||
| Intestinal absorption and unmediated permeation of sugars in post-infective tropical malabsorption (tropical sprue). | Q38952439 | ||
| Small intestinal permeability in normal Sudanese subjects: evidence of tropical enteropathy | Q39541033 | ||
| Abnormal intestinal permeability to sugars in villous atrophy | Q39574361 | ||
| Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). | Q40871673 | ||
| Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies | Q41388697 | ||
| Quantitative histological study of enteropathy associated with HIV infection | Q41863350 | ||
| Measurement in jejunal biopsies by computer-aided microscopy | Q42851833 | ||
| Investigation of intestine function during acute viral hepatitis using combined sugar oral loads | Q43196273 | ||
| Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS) | Q43568316 | ||
| Fat absorption and exocrine pancreatic function in human immunodeficiency virus infection | Q44739867 | ||
| The effect of poorly absorbed solute on intestinal absorption | Q44750490 | ||
| Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease | Q45776072 | ||
| Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus | Q45832813 | ||
| Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms | Q45839834 | ||
| Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy | Q45846771 | ||
| Kinetics of D-xylose absorption in patients with human immunodeficiency virus enteropathy | Q45852601 | ||
| Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection | Q45853016 | ||
| Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects | Q45862592 | ||
| Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas. | Q51602641 | ||
| Investigation of upper gastrointestinal symptoms in patients with AIDS | Q61054862 | ||
| European AIDS definition | Q67514256 | ||
| Small intestinal injury and parasitic diseases in AIDS | Q68887306 | ||
| Bacterial chemotactic oligopeptides and the intestinal mucosal barrier | Q69199300 | ||
| Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome | Q70082718 | ||
| Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation | Q70299057 | ||
| Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis | Q70385575 | ||
| Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease | Q70437289 | ||
| Simultaneous quantification of mannitol, 3-O-methyl glucose, and lactulose in urine by HPLC with pulsed electrochemical detection, for use in studies of intestinal permeability | Q70598649 | ||
| A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test | Q72544500 | ||
| The leaky gut of alcoholism: possible route of entry for toxic compounds | Q72571576 | ||
| Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs | Q72593596 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diarrhea | Q40878 |
| P304 | page(s) | 623-629 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea | |
| P478 | volume | 37 |
| Q34669165 | A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy |
| Q35207307 | A clinical review of micronutrients in HIV infection |
| Q57832217 | A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome |
| Q41243161 | AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection |
| Q40893639 | Advances in mucosal immunology |
| Q37586815 | Advances in sexually transmitted infections of the gastrointestinal tract |
| Q34565345 | Alterations in intestinal permeability |
| Q34425509 | Anatomical localization of commensal bacteria in immune cell homeostasis and disease |
| Q35531527 | Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection |
| Q40841822 | Assessment of intestinal permeability with a two-hour urine collection |
| Q38886643 | Comparison of intestinal function in human immunodeficiency virus-seropositive patients in Kampala and London |
| Q35128634 | Coping strategies of HIV-affected households in Ghana |
| Q77217563 | Correlation of intestinal structure and function in HIV infection |
| Q39454237 | Determinants of energy intake and energy expenditure in HIV and AIDS. |
| Q44765518 | Diarrhea in patients with AIDS. |
| Q36595308 | Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection |
| Q43840405 | Effect of octreotide on small intestinal motility in HIV-infected patients with chronic refractory diarrhea |
| Q35547031 | Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome. |
| Q35857250 | Enteric ganglionitis in rhesus macaques infected with simian immunodeficiency virus |
| Q35910518 | Enteropathies in the developing world: neglected effects on global health |
| Q33553358 | Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation |
| Q59793934 | Food elimination, food substitution, and nutrient supplementation among ARV-exposed HIV-positive persons in southern Ghana |
| Q30245375 | From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection |
| Q33626016 | Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial |
| Q71264439 | Gastrointestinal manifestations of HIV infection |
| Q35354578 | Geography of intestinal permeability and absorption |
| Q38890143 | Global issues in pediatric nutrition: AIDS. |
| Q38021495 | HIV infection and the intestinal mucosal barrier |
| Q37106314 | Host factors in amniotic fluid and breast milk that contribute to gut maturation |
| Q34668617 | Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy. |
| Q35082674 | Immunohistological characterization of intercellular junction proteins in rhesus macaque intestine |
| Q35214189 | Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age. |
| Q28367559 | Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study |
| Q43721631 | Intestinal absorption and permeability in human immunodeficiency virus-infected patients |
| Q44030733 | Intestinal absorption of D-xylose in children infected with the human immunodeficiency virus |
| Q35352791 | Intestinal permeability and inflammation in patients on NSAIDs |
| Q24629228 | Intestinal permeability defects: is it time to treat? |
| Q40251197 | Investigation of Small Bowel Abnormalities in HIV-Infected Patients Using Capsule Endoscopy. |
| Q38973447 | Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation |
| Q35841385 | Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states |
| Q35557247 | Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions |
| Q41546377 | Measurement of gut permeability using fluorescent tracer agent technology |
| Q33704002 | Micronutrients and the pathogenesis of human immunodeficiency virus infection |
| Q39307751 | Neurodevelopment: The Impact of Nutrition and Inflammation During Adolescence in Low-Resource Settings |
| Q37124381 | Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy |
| Q35352447 | Pancreatic dysfunction and its association with fat malabsorption in HIV infected children |
| Q45143856 | Parasites in patients with malabsorption syndrome: a clinical study in children and adults |
| Q33785839 | Pharmacokinetics of lamivudine & stavudine in generic fixed-dose combinations in HIV-1 infected adults in India |
| Q33812820 | Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals. |
| Q34322219 | Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection |
| Q37903384 | Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient. |
| Q41697062 | Selection and pathogenicity of Candida albicans in HIV infection |
| Q80061693 | Serology- and biopsy-proven celiac disease in a patient with AIDS: case report |
| Q35642295 | Sexually transmitted proctitis |
| Q41838610 | Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea |
| Q46793862 | Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in India |
| Q33401719 | Susceptibility to intestinal infection and diarrhoea in Zambian adults in relation to HIV status and CD4 count |
| Q35932416 | The G.U.T. of gut. |
| Q34117587 | The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redox-mediated mechanism |
| Q57221649 | The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans |
| Q83224176 | The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients |
| Q38984137 | The gut microbiome and HIV-1 pathogenesis: a two-way street |
| Q39009998 | The intestinal epithelial barrier: a therapeutic target? |
| Q43573341 | The prevalence and severity of intestinal disaccharidase deficiency in human immunodeficiency virus-infected subjects |
| Q74042620 | [The intestinal barrier: functional disorders in digestive and non-digestive diseases] |
Search more.